Biogen discontinues Alzheimer's drug Aduhelm : vimarsana.com

Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the controversial drug.

Related Keywords

, Alzheimer Association , Drug Administration , Us Centers For Medicare , Medicaid Services , Alzheimer 39s Association , Lzheimer 39s Disease , Iogen , Aduhelm , Edicare ,